Lin Ying-Cing, Huang Duen-Yi, Wang Jang-Shiun, Lin Yi-Ling, Hsieh Shie-Liang, Huang Kuo-Chin, Lin Wan-Wan
*Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Medical Sciences and Institute for Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan; Institute of Biomedical Sciences and Genomics Research Center, Academia Sinica, Taipei, Taiwan; and Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
*Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Medical Sciences and Institute for Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan; Institute of Biomedical Sciences and Genomics Research Center, Academia Sinica, Taipei, Taiwan; and Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan
J Leukoc Biol. 2015 May;97(5):825-835. doi: 10.1189/jlb.3HI0814-371RR. Epub 2015 Jan 20.
NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.
NLRP3是NLR家族中最关键的成员,因为它能检测病原体入侵的存在以及与细胞损伤相关的自身衍生分子。多项研究报告称,NLRP3炎性小体介导的半胱天冬酶-1过度激活是疾病发展的关键因素。最近的研究报告称,Syk参与病原体诱导的NLRP3炎性小体激活;然而,将Syk与NLRP3炎性小体联系起来的详细机制仍不清楚。在本研究中,我们表明Syk介导NLRP3刺激诱导的前半胱天冬酶-1的加工以及随后半胱天冬酶-1的激活。此外,Syk的激酶活性对于在HEK293T细胞重构的NLRP3炎性小体系统中增强半胱天冬酶-1的激活是必需的。衔接蛋白ASC将NLRP3与效应蛋白半胱天冬酶-1连接起来。在此,我们发现Syk可通过其激酶结构域直接与ASC和NLRP3结合,但与前半胱天冬酶-1间接相互作用。Syk可使ASC的Y146和Y187残基磷酸化,这两个残基的磷酸化对于增强ASC寡聚化和前半胱天冬酶-1的募集至关重要。总之,我们的结果揭示了一条新的分子途径,通过该途径Syk促进NLRP3炎性小体形成,这是由ASC的磷酸化导致的。因此,控制Syk活性可能对调节NLRP3炎性小体激活和治疗NLRP3相关免疫疾病有效。